Loading...
Symbols:
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
Transcripts
- American International Group Business Update Call Transcript
- Family Dollar Stores, Inc. F4Q08 (Qtr End 08/31/08) Earnings Call Transcript
- Corel Corporation F3Q08 (Qtr End 08/31/08) Earnings Call Transcript
- Wells Fargo Acquisition of Wachovia Conference Call Transcript
- Resources Connection, Inc. F1Q09 (Qtr End 08/31/08) Earnings Call Transcript
- DemandTec, Inc. F2Q09 (Qtr End 08/31/08) Earnings Call Transcript
- Global Payments, Inc. F1Q09 (Qtr End 08/31/08) Earnings Call Transcript
- AngioDynamics F1Q09 (Qtr End 8/31/08) Earnings Call Transcript
- Lawson Software F1Q09 (Qtr End 8/31/08) Earnings Call Transcript
- MSCI Inc. F3Q08 (Qtr End 08/31/08) Earnings Call Transcript
-
Editor's Picks
-
Most Popular
- Opportunity in Emerging Markets Amidst This Panic
- iPhone Sales Drastically Surpass Q4 Consensus; Apple Reaches 10m Goal
- Buy, Sell or Hold: BofA Will Strengthen as the Weak Perish
- How Much Will a Wells-Wachovia Deal Cost Taxpayers?
- Fannie and Freddie Did Not Cause This Crisis
- 36 Opportunities for the Beginning of the Bull
- Full list of Editor's Picks »
- Iceland: When Too Big to Fail Becomes Too Big to Rescue »
- Who Is Now Number One in the Banking Industry? »
- 25 Cash Cows to Ride Out the Storm- Barron's »
- 36 Opportunities for the Beginning of the Bull »
- Bailout Bill Passes; What Happens Now? »
- 3 Stocks That Are Begging To Be Bought »
- Citi Examines Its Carrots and Sticks »
- Five Energy Companies That Spell Opportunity »
- Thrown Overboard - Fast Money Recap (10/3/08) »
- Now's the Time to Buy Bank Stocks »
- Big Tech Prepares for Big Layoffs »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
Biotech Picker
1 Comment
Delcath Systems to Take on Onyx Pharma's Nexavar [view article]
It was pointed out to me that there is a misspelling of PFE's drug referenced. The correct spelling is 'Sutent', if you notice the link in point 2 the spelling is correct, but in the article I, for whatever reason, threw in an extra 't'. Sorry for that. And please do not let that get in the way of the analysis.Also it was mentioned to me that Sutent does not compete with Nexavar in liver cancer as only Nexavar is approved for this indication. Yes this is true. But please understand the main point was to tie in Pfizer because of the use doxorubicin, not necessarily Sutent.
Also I had a comment that Sutent has not shown in early trials as much promise for liver cancer as hoped. This is besides the point. In fact, according to this article - www.thehindubusinessli... - Pfizer is planning a phase III trail for liver cancer in Asia. I cannot confirm but I believe this will be testing Sutent (anyone know different please post). But even if true (that Sutent dies not work in liver cancer) this supports my analysis that the use of DOXO with Delcath PHP may draw PFE attention.
Thanks for the feedback. Jun 20 10:20 AM